Leuven MindGate’s Post

We are pleased to announce that Vasodynamics has been awarded a significant UK-Taiwan Collaborative R&D Grant from Innovate UK and Taiwan's Department of Industrial Technology, MOEA. This funding will support an international collaboration in partnership with Genenet, Anntond Ind Co Ltd, Pythia Biotech Ltd on groundbreaking R&D efforts to advance organ-on-chip technology for high-efficiency real-time monitoring in microphysiological systems. Our CEO, Ningfeng Fiona Li said: “VasoDynamics are delighted to be part of this Innovation UK Grant consortium to contribute to the innovation and development of this new groundbreaking technology. We are looking forward to taking this opportunity to participate in improving the AI-embedded toxicity screening technology to modernise and accelerate our drug discovery and validation process.”

🚀You are working with #antibodies, no matter what shape or complexity? You are looking to submit your #IND? Don't look further as Menarini Biotech can guide you from bench to clinic, from gene to vial. 🧬💉 Join our discussion at Medicon Valley Alliance with out top Menarini Biotech experts. And what better way to have great discussions than over fresh coffee and delicious croissants? ☕🥐 Let's connect, share ideas, and unlock the future of biotech together! 🌱💡

Biology Building Block - p38 BiTSA assay to measure target engagement in cells. Target: p38α/MAPK14 Assay type: Protein stabilization assay Purpose: Protein and molecule binding in cells Fast assay development: 5-7 days Throughput: 384-well plate Turnaround time: 2 days Automation: Available #BiTSA assay #Assaydevelopment #Drugscreening #HiBiT based techonology

Chicago's climb to 9th place in GEN's Top Biopharma Clusters list underscores our city's growing magnetism for life sciences innovation and company expansion. We're seeing more biotech firms choosing Chicago for their growth, attracted by our world-class research institutions, skilled workforce, and supportive ecosystem. This ranking reflects the hard work of our community and signals to the industry that Chicago is not just a place for startups, but a prime location for established companies to scale and thrive

Thrilled to see Chicago climb to 9th place in GEN’s 2024 Top Biopharma Clusters, surpassing Seattle! Key drivers of our rise: - Growth in wet lab developments - Chan Zuckerberg Initiative expansion - Booming AI sector As venture capital markets recover, attracting more investment will be crucial to sustaining this momentum. Stay tuned for the Illinois Biotechnology Innovation Organization (iBIO) economic report for deeper insights into our biopharma growth. #Biopharma #Chicago #Innovation #AI #Investment #GENrankings Read more on iBIO NewsBrief.

Ready to Revolutionize Drug Discovery? Our groundbreaking Bioluminescent Thermal Shift Assay (BiTSA) is making this a reality! Imagine detecting drug-target interactions with precision and speed. BiTSA combines high sensitivity with high-throughput capabilities, providing the crucial data you need to accelerate your drug discovery process. Want to see BiTSA in action? Check out our latest case study and discover how we're transforming drug development. Click here to learn more: https://lnkd.in/g3RQ_aAu

🌟 Exciting Partnership announcement! 🌟 Stilla Technologies, a pioneer in digital PCR systems, has forged a strategic distribution partnership with Avantor to bring their innovative dPCR products to the US market! 🇺🇸🔬 Under this new agreement, Avantor's life science specialists will make Stilla's advanced dPCR solutions available to researchers and clinicians across the country. 🧬💼 "With Avantor's backing, we are well positioned to achieve our biopharma, applied testing, and academia objectives while enhancing our applications to better serve our customers," shared Kerri McWeeny, Stilla's GM for North America. Highlights: 🔹 Stilla launched the seven-color Nio+ dPCR instrument last year. 🔹 Secured a $26.5M Series C financing round for scaling and commercialization. 🔹 Avantor's history of strategic acquisitions and partnerships, including Puritan Medical Products , VWR, part of Avantor, and Oxford Nanopore Technologies. This partnership is set to propel advancements in biopharma, applied testing, and academic research, driving innovation and excellence in the life sciences sector. 🌐🚀 #DigitalPCR #Biotech #LifeSciences #Research #Innovation #Partnership #StillaTechnologies #Avantor #Biopharma #ScientificResearch #HealthcareInnovation 🌟🔬💼

⚡️ Avantor Opens New Jersey Research and Development Facility 💊 Avantor, a global provider of products and services to customers in the life sciences and advanced technology industries, has announced… ➡️ Read more: https://lnkd.in/e8_Qie_Q 🌐 Register for free focused news service covering the latest developments in relation to pharmaceutical supply: https://lnkd.in/eitNb3gD #pharma #pharmanews #APIupdates #offpatent #data #analysis #investments

Save the Date! - The 7th TPD & Induced Proximity Summit Boston - October 28th - 31st. We're currently developing the 7th edition of the worlds leading and, I believe largest gathering of TPD & Induced Proximity experts, representing a whos-who of one of the most promising, exciting and rapidly developing areas of drug discovery and development. Set to return to Boston this October, the meeting is the go-to, not to be missed event if you're working in, or interested in this field, boasting the most comprehensive end to end agenda to date. Agenda launch in the coming weeks! 2024 already feels like yet another incredibly exciting year for the TPD community, from successful IND applications, new biotech launches, preclinical and clinical updates, massive deals and strategic collaborations, positive data and much more! Want to refresh on what's happened this year so far? 29 major headlines relating to 33 leading companies that I've spotted - feel free to check them out in case you missed anything: https://lnkd.in/ewcP6zgh

At the core of our CDMO-heart is a deep-rooted commitment to the life sciences community. 💗 That's why we at NorthX Biologics are proud to regularly engage with students, sharing our expertise and insights while learning from the next generation of innovators. These interactions inspire us to continue building bridges between industry and academia, fostering an environment where scientific progress and innovation can thrive. We're excited to keep pushing the boundaries of what's possible, together. The future of life sciences has never looked brighter. 🌞 Uppsala University | Umeå University Christoffer Ahlström | Johan Persäter | Luisa Lundin #BeyondCDMO